Company Filing History:
Years Active: 2021
Title: Innovations of Cheong-Sei Kim in Botulinum Toxin Composition
Introduction
Cheong-Sei Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of stable liquid compositions that incorporate botulinum toxin. His work aims to enhance user convenience and improve the stability of the active ingredient.
Latest Patents
One of Cheong-Sei Kim's key patents is a stable liquid composition comprising botulinum toxin. This innovative formulation is ready-to-use without the need for a reconstitution process. This advancement not only improves user convenience but also reduces the risk of activity deviation due to dilution errors during reconstitution. The composition effectively prevents the aggregation of botulinum toxin, even at low concentrations, ensuring excellent storage stability. Additionally, it minimizes the adsorption of the toxin to containers, thereby maintaining its activity consistently across batches and vials. This patent highlights his commitment to enhancing the efficacy and reliability of botulinum toxin applications.
Career Highlights
Cheong-Sei Kim is associated with Daewoong Co., Ltd., a prominent company in the pharmaceutical industry. His work at Daewoong has positioned him as a key player in the development of innovative medical solutions. His expertise in botulinum toxin formulations has contributed to advancements in therapeutic applications.
Collaborations
Cheong-Sei Kim collaborates with Hyeona Yim, who is also involved in the research and development of similar innovations. Their partnership exemplifies the collaborative spirit in the field of biotechnology, driving forward the boundaries of what is possible in medical treatments.
Conclusion
Cheong-Sei Kim's contributions to the field of botulinum toxin compositions reflect his dedication to innovation and improving medical practices. His patent for a stable liquid composition showcases the potential for enhanced user convenience and product reliability. Through his work, he continues to make a significant impact in the biotechnology sector.